MedPath

Transdiagnostic Cognitive Biomarkers

Not Applicable
Recruiting
Conditions
Depression
Pain
Interventions
Behavioral: Computer game/task
Behavioral: Health surveys online
Registration Number
NCT04864080
Lead Sponsor
University of Minnesota
Brief Summary

The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as healthy controls.

Detailed Description

This study aims to test the feasibility of procedures aimed at discovering transdiagnostic biomarkers for cognitive impairment in chronic pain and depression. Fifteen healthy control participants and 15 participants from each disease group (chronic pain, depression) will be recruited.

Using a task-based fmri, TMS will be targeted for priming of the Left DLPFC. EEG will be used during our behavioral paradigm to compare changes in DLPFC function before and after primed TMS.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Have access to the online study platform.
Read More
Exclusion Criteria
  • under 18, non-English speaking

Arm 2: pain and depression:

Inclusion Criteria:

  • Pain or depression

Exclusion Criteria:

  • pregnant women
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Healthy Comparison GroupComputer game/taskBehavioral tasks and surveys online.
Healthy Comparison GroupHealth surveys onlineBehavioral tasks and surveys online.
Pain/Depression patients from clinicHealth surveys onlineMRI, TMS and EEG, and behavioral tasks and surveys online.
Pain/Depression patients from clinicComputer game/taskMRI, TMS and EEG, and behavioral tasks and surveys online.
Primary Outcome Measures
NameTimeMethod
Feasibility for all aspects of the study1-7 days

Feasibility; the overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex that are translatable across disease groups in order to more accurately phenotype clusters of cognitive dysfunction. Completing behavioral paradigms with electrophysiology and TMS is a challenging frontier. This study focuses on the feasibility of such an endeavor for those with chronic pain or depression as well as healthy controls.

Secondary Outcome Measures
NameTimeMethod
Acceptability1-7 days

Sum total of acceptability rating scale of study procedures.

Trial Locations

Locations (1)

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath